GM: The drug you use to bind those two components is a phthalimide, which has a contentious history. GW: Yes. The first phthalimide that you’ll have heard of is called thalidomide. It was ...

Avadomide hydrochloride is under clinical development by Bristol-Myers Squibb and currently in Phase I for Glioblastoma Multiforme (GBM).

Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg12O12 and Zn12O12 nanoclusters: an in silico strategy for COVID-19 treatment.

Avadomide hydrochloride is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor.